Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Dna Methylation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Dna Methylation is a biological pathway involved in neurodegeneration research. Key relationships include: associated with, therapeutic target, regulates. Associated with ALS, Aging, Als. Connected to 496 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | Dna Methylation |
| Key Genes/Proteins | ABCB1, ABCG1, ACE, Actin, ADRA1A, ADRA1B |
| Related Diseases | aging, Aging, Als |
| Related Pathways | Akt |
Knowledge base pages for this entity
graph TD
Dna_Methylation["Dna Methylation"] -->|"interacts"| Wnt["Wnt"]
Dna_Methylation["Dna Methylation"] -->|"interacts"| Epigenetic["Epigenetic"]
Dna_Methylation["Dna Methylation"] -->|"interacts"| Mtor["Mtor"]
Dna_Methylation["Dna Methylation"] -->|"interacts"| Akt["Akt"]
Dna_Methylation["Dna Methylation"] -->|"interacts"| Pi3K["Pi3K"]
IDH1["IDH1"] -->|"therapeutic target"| Dna_Methylation["Dna Methylation"]
VEGFA["VEGFA"] -->|"therapeutic target"| Dna_Methylation["Dna Methylation"]
MDM4["MDM4"] -->|"therapeutic target"| Dna_Methylation["Dna Methylation"]
APOB["APOB"] -->|"therapeutic target"| Dna_Methylation["Dna Methylation"]
style Dna_Methylation fill:#1b5e20,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Neurological Disorders | involved_in | disease | 0.95 |
| Human Aging | biomarker_for | process | 0.95 |
| mammalian brain development | involved_in | process | 0.95 |
| Neurodegenerative Diseases | involved_in | disease | 0.95 |
| Progression Of Neurological Disorders | contributes_to | phenotype | 0.90 |
| PI3K/AKT/mTOR | regulates | pathway | 0.90 |
| Therapy Resistance | contributes_to | phenotype | 0.90 |
| BRAIN DEVELOPMENT | involved_in | entity | 0.90 |
| Mammalian Brain Development | mediates | process | 0.90 |
| Thyroid Cancer | involved_in | disease | 0.90 |
| Mitochondrial Dysfunction Gene Expression | regulates | process | 0.90 |
| learning and memory | regulates | phenotype | 0.90 |
| frontal cortex | expressed_in | brain_region | 0.90 |
| CRHBP | regulates | gene | 0.85 |
| Gene Expression | regulates | process | 0.85 |
| Primary Open Angle Glaucoma | involved_in | disease | 0.85 |
| CORTEX | expressed_in | entity | 0.85 |
| synaptic plasticity | involved_in | process | 0.85 |
| CRH | regulates | gene | 0.85 |
| CRHR1 | regulates | gene | 0.85 |
| Clear-Cell Renal Cell Carcinoma | biomarker_for | disease | 0.85 |
| Clear-Cell Renal Cell Carcinoma | involved_in | disease | 0.85 |
| Post-Stroke Depression | involved_in | disease | 0.85 |
| HPA axis | regulates | pathway | 0.80 |
| Hypersexual Disorder | biomarker_for | disease | 0.80 |
| Gene expression | regulates | process | 0.80 |
| neurological disorders | associated_with | disease | 0.80 |
| Disease Prevention | involved_in | process | 0.75 |
| Central Precocious Puberty | mediates | disease | 0.75 |
| Forensics | involved_in | process | 0.70 |
| gene transcription | regulates | process | 0.70 |
| Parkinson's Disease | regulates | disease | 0.70 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| P53 | processes | gene | 0.65 |
| NRF2 | processes | gene | 0.65 |
| UBIQUITIN | activates | gene | 0.65 |
| AGING | interacts_with | phenotype | 0.65 |
| KEAP1 | processes | gene | 0.65 |
| MTOR | processes | gene | 0.65 |
| PI3K | processes | gene | 0.65 |
| HTT | interacts_with | gene | 0.60 |
| STING | interacts_with | gene | 0.60 |
| T CELLS | regulates | cell_type | 0.60 |
| T CELL | regulates | cell_type | 0.60 |
| NEURODEGENERATION | regulates | disease | 0.60 |
| SYNAPTIC PLASTICITY | protects_against | phenotype | 0.60 |
| P300 | regulates | gene | 0.60 |
| NEURONS | treats | cell_type | 0.60 |
| AUTOPHAGY | inhibits | phenotype | 0.60 |
| TUMOR | expressed_in | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Als | regulates | disease | 1.00 |
| DNA | inhibits | gene | 1.00 |
| DNA | activates | gene | 1.00 |
| Als | associated_with | disease | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| CANCER | regulates | gene | 1.00 |
| Cancer | regulates | disease | 1.00 |
| DNA | associated_with | gene | 1.00 |
| GENES | associated_with | gene | 1.00 |
| DNA | regulates | gene | 1.00 |
| GENES | regulates | gene | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| entities-dna-methylation | describes | wiki | 1.00 |
| Cancer | expressed_in | disease | 1.00 |
| INFLAMMATION | regulates | gene | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| Als | treats | disease | 1.00 |
| CANCER | expressed_in | gene | 1.00 |
| APOPTOSIS | regulates | gene | 1.00 |
| Gut Microbiota | modulates | process | 0.95 |
| dCas9-Dnmt3a | associated_with | protein | 0.90 |
| dCas9-Tet1 | associated_with | protein | 0.90 |
| 28798132 | distinguishes and marks | paper | 0.90 |
| 28798132 | distinguishes | paper | 0.90 |
| DNA | expressed_in | gene | 0.90 |
| Als | expressed_in | disease | 0.90 |
| Cancer | therapeutic_target | disease | 0.90 |
| GENES | therapeutic_target | gene | 0.90 |
| Aging | associated_with | disease | 0.90 |
| Tumor | therapeutic_target | disease | 0.90 |
| Tumor | regulates | disease | 0.90 |
| PSME2 | associated_with | gene | 0.85 |
| 2-hydroxyglutarate | promotes | compound | 0.85 |
| HSV-gB | modulates | protein | 0.80 |
| PSME2 | correlates_with | gene | 0.80 |
| OVERVIEW | treats | gene | 0.80 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.80 |
| Inflammation | associated_with | disease | 0.80 |
| Tumor | expressed_in | disease | 0.80 |
| INFLAMMATION | associated_with | gene | 0.80 |
| AGING | associated_with | gene | 0.80 |
| Tumor | associated_with | disease | 0.80 |
| AUTOPHAGY | regulates | gene | 0.80 |
| CANCER | inhibits | gene | 0.80 |
| GENES | inhibits | gene | 0.80 |
| DNA | therapeutic_target | gene | 0.80 |
| DNA | causes | gene | 0.80 |
| ALZHEIMER | associated_with | gene | 0.80 |
| OXIDATIVE STRESS | regulates | gene | 0.80 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] | Yu CH, Davidson S, Harapas CR, Hilton JB | Cell | 2020 | 2 |
| Genome-wide methylation profiles reveal quantitative views of human aging rates. [PMID:23177740] | Hannum G, Guinney J, Zhao L, Zhang L, Hu | Mol Cell | 2013 | 1 |
| DNA methylation and prediction of biological age. [PMID:41602542] | Chen Y, Cheng X, Ji S | Front Mol Biosci | 2025 | 0 |
| Causality-enriched epigenetic age uncouples damage and adaptation. [PMID:38243142] | Ying K, Liu H, Tarkhov AE | Nat Aging | 2024 | 0 |
| PARP1-DNA co-condensation drives DNA repair site assembly to prevent disjunction [PMID:38320550] | Chappidi, Quail, Doll, Vogel, Aleksandro | Cell | 2024 | 0 |
| DNA-Origami-Armored DNA Condensates. [PMID:39075031] | Yamashita, Sato, Suzuki, Ishikawa, Takin | Chembiochem : a European journ | 2024 | 0 |
| PARP1-DNA co-condensation drives DNA repair site assembly to prevent disjunction [PMID:38320550] | Chappidi Nagaraja; Quail Thomas; Doll Si | Cell | 2024 | 0 |
| Causality-enriched epigenetic age uncouples damage and adaptation. [PMID:38243142] | Ying K, Liu H, Tarkhov AE, Sadler MC, Lu | Nature aging | 2024 | 0 |
| DNA-Origami-Armored DNA Condensates. [PMID:39075031] | Unknown | Chembiochem : a European journ | 2024 | 0 |
| Single substitution in H3.3G34 alters DNMT3A recruitment to cause progressive ne [PMID:36931244] | Khazaei Sima; Chen Carol C L; Andrade Au | Cell | 2023 | 0 |
| Neurodegeneration and epigenetics: A review. [PMID:37344098] | Ghosh P, Saadat A | Neurologia (Engl Ed) | 2023 | 0 |
| Regulation of Human DNA Primase-Polymerase PrimPol. [PMID:37758313] | Boldinova, Makarova | Biochemistry. Biokhimiia | 2023 | 0 |
| Global identification of SWI/SNF targets reveals compensation by EP400. [PMID:37922899] | Martin BJE, Ablondi EF, Goglia C | Cell | 2023 | 0 |
| Regulation of Human DNA Primase-Polymerase PrimPol. [PMID:37758313] | Unknown | Biochemistry. Biokhimiia | 2023 | 0 |
| Neurodegeneration and epigenetics: A review. [PMID:37344098] | ["Ghosh P", "Saadat A"] | Neurologia | 2023 | 0 |
| Site-specific mitochondrial dysfunction in neurodegeneration. [PMID:35182728] | Vodičková A, Koren SA, Wojtovich AP | Mitochondrion | 2022 | 0 |
| Chromatin accessibility profiling by ATAC-seq. [PMID:35478247] | Grandi Fiorella C; Modi Hailey; Kampman | Nature protocols | 2022 | 0 |
| DNA damage and repair in age-related inflammation. [PMID:35831609] | Zhao Yang; Simon Matthew; Seluanov Andre | Nature reviews. Immunology | 2022 | 0 |
| Bone remodeling: an operational process ensuring survival and bone mechanical co [PMID:35851054] | Bolamperti Simona; Villa Isabella; Rubin | Bone research | 2022 | 0 |
| Chromatin accessibility profiling by ATAC-seq. [PMID:35478247] | Unknown | Nature protocols | 2022 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning Dna Methylation in their description or question text
Score: 0.342 · neurodegeneration · 2026-04-26
A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective ada
Score: 0.327 · neurodegeneration · 2026-04-26
A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective ada
Score: 0.326 · neurodegeneration · 2026-04-26
The same signal may be beneficial early and damaging late. Testing protective chromatin remodeling with single-cell meth